Avid Radiopharmaceuticals is pioneer in the field of molecular imaging, developing products with the potential for more effective detection, diagnosis and monitoring of major chronic human diseases.
Location: United States, Pennsylvania, Philadelphia
Total raised: $26M
Investors 2
| Date | Name | Website |
| - | Alta Partn... | altapartne... |
| - | Tectonic V... | tectonicve... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 09.05.2007 | - | $26M | - |
Mentions in press and media 4
| Date | Title | Description |
| 28.09.2023 | What The 2023 Nucleus Awards Winners Hope For Philly’s Innovation Future | Philly has the talent to succeed as an innovation hub, but its people and organizations need to believe in themselves more to make it happen. This was one of the themes discussed by leaders of Philadelphia’s STEM community at the University... |
| 14.12.2020 | Targeted Radiopharmaceuticals Company RayzeBio Raises $105 Million | RayzeBio — a company that is developing a broad pipeline of targeted radiopharmaceuticals against validated solid tumor targets — announced that it has raised $105 million in Series B funding led by Venrock Healthcare Capital Partners Rayze... |
| 22.05.2009 | Avid Radiopharmaceuticals closes $34.5m funding round | The round was led by venture capital firm Alta Partners, which was joined by existing investors Pfizer Venture Investmen |
| 09.05.2007 | Avid Radiopharmaceuticals, maker of imaging reagents, raises $26M for clinical trials | Avid Radiopharmaceuticals, a Philadelphia-based maker of “molecular imaging agents” that help highlight diseased tissue in various medical scans, raised $26 million in a third round to develop early-detection products for Alzheimer’s and Pa... |